Palabras clave
Cefalea
Trombosis venosa cerebral
ictus
SARS-CoV-2
Categorías
Cómo citar
Resumen
Resumen:
La infección por SARS-CoV-2, responsable de COVID-19 ha demostrado potencial neurotrópico y neuroinvasor, exhibiendo múltiples manifestaciones neurológicas que varÃan de leves a severas, estas últimas relacionadas a un estado protrombótico que da lugar a la aparición de accidentes cerebrovasculares y con menor frecuencia trombosis venosa cerebral. La fisiopatologÃa de estos eventos actualmente se relaciona con varios mecanismos incluyendo trombo-inflamación, endoteliopatia y estasis sangÃnea en pacientes crÃticos.
La trombosis venosa cerebral es una complicación posible de COVID-19 en cualquier etapa, incluso en pacientes con curso no severo de la enfermedad, en estas condiciones probablemente asociado a disfunción microvascular potenciada por condiciones comorbidas protrombóticas.
Referencias
Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, et al. Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26(7):1017-32. doi: 10.1038/s41591-020-0968-3
Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020; 77(6):683-690. doi: 10.1001/jamaneurol.2020.1127
Han H, Yang L, Liu R, Liu F, Wu KL, Li J, et al. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin Chem Lab Med. 2020;58(7):1116-20. doi: 10.1515/cclm-2020-0188
Bhatia R, Srivastava MVP. COVID-19 and Stroke: Incidental, Triggered or Causative. Ann Indian Acad Neurol. 2020;23(3):318-24. doi: 10.4103/aian.AIAN_380_20.
Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood. 2020;135(23):2033-40. doi: 10.1182/blood.2020006000
Al-Samkari H, Karp Leaf RS, Dzik WH, Carlson JC, Fogerty AE, Waheed A, et al. COVID and Coagulation: Bleeding and Thrombotic Manifestations of SARS-CoV2 Infection. Blood. 2020;135(23):2033-2040. doi: 10.1182/blood.2020006000
Shi W, Lv J, Lin L. Coagulopathy in COVID-19: Focus on vascular thrombotic events. J Mol Cell Cardiol. 2020;146:32-40. doi: 10.1016/j.yjmcc.2020.07.003
Li Y, Li M, Wang M, Zhou Y, Chang J, Xian Y, et al. Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study. Stroke Vasc Neurol. 2020;5(3):279-284. doi: 10.1136/svn-2020-000431
Sweid A, Hammoud B, Bekelis K, Missios S, Tjoumakaris SI, Gooch MR, et al. Cerebral ischemic and hemorrhagic complications of coronavirus disease 2019. Int J Stroke. 2020;15(7):733-742. doi: 10.1177/1747493020937189
Hughes C, Nichols T, Pike M, Subbe C, Elghenzai S. Cerebral Venous Sinus Thrombosis as a Presentation of COVID-19. Eur J Case Rep Intern Med. 2020;7(5):001691. doi: 10.12890/2020_001691
Garaci F, Di Giuliano F, Picchi E, Da Ros V, Floris R. Venous cerebral thrombosis in COVID-19 patient. J Neurol Sci. 2020;414:116871. doi: 10.1016/j.jns.2020.116871
Hemasian H, Ansari B. First case of Covid-19 presented with cerebral venous thrombosis: A rare and dreaded case. Rev Neurol (Paris). 2020;176(6):521-523. doi: 10.1016/j.neurol.2020.04.013
Poillon G, Obadia M, Perrin M, Savatovsky J, Lecler A. Cerebral venous thrombosis associated with COVID-19 infection: Causality or coincidence? J Neuroradiol. 2020;S0150-9861(20)30167-X. doi: 10.1016/j.neurad.2020.05.003
Dahl-Cruz F, Guevara-Dalrymple N, López-Hernández N. [Cerebral venous thrombosis and SARS-CoV-2 infection]. Rev Neurol. 2020;70(10):391-392. doi: 10.33588/rn.7010.2020204
Klein DE, Libman R, Kirsch C, Arora R. Cerebral venous thrombosis: A typical presentation of COVID-19 in the young. J Stroke Cerebrovasc Dis. 2020;29(8):104989. doi: 10.1016/j.jstrokecerebrovasdis.2020.104989
Malentacchi M, Gned D, Angelino V, Demichelis S, Perboni A, Veltri A, et al. Concomitant brain arterial and venous thrombosis in a COVID-19 patient. Eur J Neurol. 2020; 10.1111/ene.14380. doi: 10.1111/ene.14380
Chougar L, Mathon B, Weiss N, Degos V, Shor N. Atypical Deep Cerebral Vein Thrombosis with Hemorrhagic Venous Infarction in a Patient Positive for COVID-19. AJNR Am J Neuroradiol. 2020;41(8):1377-79. doi: 10.3174/ajnr.A6642
Cavalcanti DD, Raz E, Shapiro M, Dehkharghani S, Yaghi S, Lillemoe K, et al. Cerebral Venous Thrombosis Associated with COVID-19. AJNR Am J Neuroradiol. 2020;41(8):1370-76. doi: 10.3174/ajnr.A6644
Baudar C, Duprez T, Kassab A, Miller N, Rutgers MP. COVID-19 as triggering co-factor for cortical cerebral venous thrombosis? J Neuroradiol. 2020;S0150-9861(20)30205-4. doi: 10.1016/j.neurad.2020.06.008
Roy-Gash F, De Mesmay M, Devys JM, Vespignani H, Blanc R, Engrand N. COVID-19-associated acute cerebral venous thrombosis: clinical, CT, MRI and EEG features. Crit Care. 2020;24(1):419. doi: 10.1186/s13054-020-03131-x
Bolaji P, Kukoyi B, Ahmad N, Wharton C. Extensive cerebral venous sinus thrombosis: a potential complication in a patient with COVID-19 disease. BMJ Case Rep. 2020;13(8):e236820. doi: 10.1136/bcr-2020-236820
Saposnik G, Barinagarrementeria F, Brown RD, Bushnell CD, Cucchiara B, Cushman M, et al. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42(4):1158-92. doi: 10.1161/STR.0b013e31820a8364
Abou-Ismail MY, Diamond A, Kapoor S, Arafah Y, Nayak L. The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management. Thrombosis Research. 2020;194:101-115. doi: 10.1016/j.thromres.2020.06.029
Atallah B, Mallah SI, AlMahmeed W. Anticoagulation in COVID-19. Eur Heart J Cardiovasc Pharmacother. 2020;6(4):260-261. doi: 10.1093/ehjcvp/pvaa036
Mummery RS, Rider CC. Characterization of the heparin-binding properties of IL-6. J Immunol. 2000 ;165(10):5671-9. doi: 10.4049/jimmunol.165.10.5671
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
Derechos de autor 2021 Ictus